Automotive Cell-Signaling-Market-by-Type-Endocrine-Paracrine- | Page 7

11.4 ASIA 132 11.4.1 CHINA 137 11.4.2 JAPAN 141 11.4.3 INDIA 146 11.4.4 REST OF ASIA (ROA) 149 11.5 REST OF THE WORLD (ROW) 152 12 COMPETITIVE LANDSCAPE 157 12.1 INTRODUCTION 157 12.2 VENDOR DIVE OVERVIEW 157 12.2.1 VANGUARDS 157 12.2.2 INNOVATORS 157 12.2.3 DYNAMIC PLAYERS 157 12.2.4 EMERGING PLAYERS 157 12.3 COMPETITIVE BENCHMARKING 159 12.3.1 PRODUCT OFFERINGS (FOR ALL 25 PLAYERS) 159 12.3.2 BUSINESS STRATEGY (FOR ALL 25 PLAYERS) 160 *Top 25 companies analyzed for this study are - Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany), Full Moon BioSystems, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Cisbio Bioassays (France), Rockland Immunochemicals Inc. (U.S.), BioVision, Inc. (U.S.), Tonbo Biosciences (U.S.), BPS Bioscience, Inc. (U.S.), StressMarq Biosciences Inc. (U.S.), Abeomics, Inc. (U.S.), Sino Biological, Inc. (U.S.), RayBiotech, Inc. (U.S.), MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. (Japan), and Santa Cruz Biotechnology, Inc. (U.S.) 13 COMPANY PROFILES 161 (OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*